NCT07469618

Brief Summary

The aim of this study is to determine if integrating a culturally congruent indigenous stress reduction intervention into Cognitive Stimulation Therapy (CST) enhances cognitive outcomes in Pakistani adults with Mild Cognitive Impairment (MCI).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Mar 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Mar 2026Jun 2026

Study Start

First participant enrolled

March 1, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

March 4, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 4, 2026

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Montreal Cognitive Assessment (MoCA) total score from baseline to 7 weeks

    The Montreal Cognitive Assessment (MoCA) will be used to assess overall cognitive functioning, including attention, memory, language, executive functions, and visuospatial abilities. The MoCA total score ranges from 0 to 30, with higher scores indicating better cognitive functioning. Assessments will be conducted at baseline and after completion of the 7-week intervention period.

    7 weeks

Study Arms (3)

Cognitive Stimulation Therapy integrated with Stress Reduction Intervention

EXPERIMENTAL

Participants receive Cognitive Stimulation Therapy integrated with Stress Reduction Intervention for 7 weeks.

Behavioral: Cognitive Stimulation Therapy integrated with Stress Reduction Intervention

Cognitive Stimulation Therapy (CST)

ACTIVE COMPARATOR

Participants receive Cognitive Stimulation Therapy sessions for 7 weeks.

Behavioral: Cognitive Stimulation Therapy

Control Group

NO INTERVENTION

Participants will not receive any structured therapy during the 7 week study period.

Interventions

Participants in this Arm will receive Cognitive Stimulation Therapy integrated with Stress Reduction Intervention for 7 weeks, combining structured cognitive exercises targeting memory, attention, and problem-solving with guided stress reduction techniques.

Cognitive Stimulation Therapy integrated with Stress Reduction Intervention

Participants in this Arm will attend Cognitive Stimulation Therapy sessions only for 7 weeks, including structured cognitive exercises targeting memory, attention, and problem-solving in a group format.

Cognitive Stimulation Therapy (CST)

Eligibility Criteria

Age45 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 45 years and above
  • Individuals with education up to Matric
  • Individuals who obtain a score lower than 23 on Montreal Cognitive Assessment (MoCA) suggesting the presence of cognitive decline.
  • Individuals who obtain a score of 14 or more on the Perceived Stress Scale suggesting increased levels of perceived stress (moderate and high)
  • Individuals who obtain score ranged from 13 to 25 (Poor to Adequate) on Quality of Life in Alzheimer's Disease (Qol-AD)

You may not qualify if:

  • Diagnosis of dementia or major neurocognitive disorder
  • Presence of severe psychiatric illness (e.g., psychosis, major depressive episode)
  • Significant hearing or visual impairments that interfere with participation
  • Currently undergoing psychological or cognitive therapy
  • Any neurological condition that may interfere with cognitive assessment (e.g., stroke, Parkinson's disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student

Study Record Dates

First Submitted

March 4, 2026

First Posted

March 13, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

March 13, 2026

Record last verified: 2026-03